Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
To design effective and patient-specific cancer therapy, sensitive detection of relapse and distant metastases by non-invasive medical imaging is essential, for which MRI offers tremendous potential due to wide availability of the equipment in clinic and avoidance of ionizing radiation. Although gadolinium-based contrast agents are the most frequently used for MRI, they are associated with nephrogenic systemic fibrosis and brain deposition. Thus, less toxic manganese ions (Mn2+) are exploited as an alternative for tumor detection using MRI. Yet, the current formulations of Mn2+ cannot provide desirable results due to low tumor uptake after systemic administration. To address the need, Nanology Labs offers a novel manganese-based MRI contrast agent which is able to detect solid tumors and brain metastasis at early stages. In this project we aim at scaling-up the formulation prototyping for scale up industry manufacturing.
Jeffrey Henderson
Mohammad Amini
Nanology Labs Inc.
Pharmacy / Pharmacology
Pharmaceuticals
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.